anmelden
NASDAQ 100
29.216,50
PKT
+652,55
PKT
+2,28
%
Indikation*
29.234,99
PKT
+671,05
PKT
+2,35
%
Offiziell
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.10.11 | Apple buy | Société Générale Group S.A. (SG) | |
| 17.10.11 | Alphabet A (ex Google) overweight | JP Morgan Chase & Co. | |
| 17.10.11 | Microchip Technology overweight | Barclays Capital | |
| 17.10.11 | Alphabet A (ex Google) buy | Banc of America Securities-Merrill Lynch | |
| 17.10.11 | Alphabet A (ex Google) overweight | Barclays Capital | |
| 17.10.11 | Walmart equal-weight | Morgan Stanley | |
| 17.10.11 | Alphabet A (ex Google) kaufen | Independent Research GmbH | |
| 17.10.11 | Alphabet A (ex Google) outperform | Raymond James Financial, Inc. | |
| 17.10.11 | Alphabet A (ex Google) outperform | Oppenheimer & Co. Inc. | |
| 17.10.11 | Apple outperform | Robert W. Baird & Co. Incorporated | |
| 17.10.11 | Alphabet A (ex Google) outperform | Credit Suisse Group | |
| 14.10.11 | Alphabet A (ex Google) outperform | RBC Capital Markets | |
| 14.10.11 | Alphabet A (ex Google) buy | Needham & Company, LLC | |
| 14.10.11 | Alphabet A (ex Google) outperform | RBC Capital Markets | |
| 14.10.11 | Biogen outperform | RBC Capital Markets | |
| 14.10.11 | Apple buy | UBS AG | |
| 14.10.11 | Alphabet A (ex Google) buy | UBS AG | |
| 14.10.11 | Walmart overweight | Barclays Capital | |
| 14.10.11 | Exelon outperform | RBC Capital Markets | |
| 14.10.11 | eBay equal-weight | Barclays Capital | |
| 14.10.11 | Alphabet A (ex Google) kaufen | Fuchsbriefe | |
| 14.10.11 | Intel buy | UBS AG | |
| 14.10.11 | eBay buy | Banc of America Securities-Merrill Lynch | |
| 14.10.11 | Regeneron Pharmaceuticals neutral | Citigroup Corp. | |
| 14.10.11 | Biogen neutral | Citigroup Corp. | |
| 14.10.11 | Microsoft outperform | Credit Suisse Group | |
| 14.10.11 | Intel overweight | Barclays Capital | |
| 14.10.11 | Apple sector perform | Scotia Capital Markets | |
| 14.10.11 | PepsiCo overweight | Barclays Capital | |
| 14.10.11 | Cisco outperform | Oppenheimer & Co. Inc. | |
| 14.10.11 | PepsiCo neutral | Goldman Sachs Group Inc. | |
| 14.10.11 | Microsoft overweight | Morgan Stanley | |
| 14.10.11 | Intel outperform | Raymond James Financial, Inc. | |
| 13.10.11 | Monster Beverage buy | Stifel, Nicolaus & Co., Inc. | |
| 13.10.11 | Linde buy | UniCredit Research | |
| 13.10.11 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |
| 13.10.11 | PepsiCo buy | UBS AG | |
| 13.10.11 | Fiserv buy | D.A. Davidson & Co. | |
| 13.10.11 | Microsoft buy | Nomura | |
| 13.10.11 | Alphabet A (ex Google) overweight | Barclays Capital |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.